Prelude Therapeutics (PRLD)
undefined
undefined%
At close: undefined
0.83
3.24%
After-hours Dec 13, 2024, 05:22 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 25.29M 30.61M 31.83M 218.31M 18.88M 15.60M
Short-Term Investments 207.64M 171.12M 259.40M - - -
Long-Term Investments - 4.04M 4.04M - - -
Other Long-Term Assets 4.34M 5.38M 303.00K 301.00K - -
Receivables - - - - - -
Inventory - - - - - -
Other Current Assets 2.65M 2.65M 7.76M 5.00M 1.34M -
Total Current Assets 235.59M 204.38M 295.12M 220.81M 20.22M 15.60M
Property-Plant & Equipment 37.74M 6.70M 5.64M 2.48M 1.65M 811.00K
Goodwill & Intangibles - - - - - -
Total Long-Term Assets 42.08M 16.12M 9.98M 2.78M 1.65M 811.00K
Total Assets 277.67M 220.50M 305.10M 223.59M 21.87M 16.41M
Account Payables 4.58M 6.78M 7.84M 3.92M 1.97M 1.36M
Deferred Revenue - - - - - -
Short-Term Debt 2.96M 3.66M 3.48M - 258.00K -
Other Current Liabilities 14.29M 11.26M 7.88M 7.46M 2.60M 1.08M
Total Current Liabilities 21.83M 21.70M 19.20M 11.38M 4.83M 2.45M
Long-Term Debt 15.41M - - - - -
Other Long-Term Liabilities 3.34M 3.36M - 32.00K 66.45M 36.65M
Total Long-Term Liabilities 18.75M 3.36M - 32.00K 66.45M 36.65M
Total Liabilities 40.58M 25.06M 19.20M 11.41M 71.28M 39.10M
Total Debt 16.89M 1.83M 1.74M - 258.00K -
Common Stock 5.00K 5.00K 5.00K 4.00K - -
Retained Earnings -456.39M -334.56M -219.12M -107.43M -50.50M -22.93M
Comprehensive Income 223.00K -1.69M -711.00K -223.59M - -191.00K
Shareholders Equity 237.09M 195.44M 285.90M 212.18M -49.41M -22.69M
Total Investments 207.64M 171.12M 259.40M - - -